vaccine efficacy , measured by reduction in febrile or systemic illness in vaccines , compared with that in controls was 100 % for ca h3n2 vaccine , 84 % for inactivated h3n2 vaccine , 79 % for ca h1n1 vaccine , and 67 % for inactivated h1n1 vaccine .
C0042210
vaccine
C0042212
inactivated